| Challenges of BDNF-based therapies: From common to rare diseases C Miranda-Lourenço, L Ribeiro-Rodrigues, J Fonseca-Gomes, ... Pharmacological Research 162, 105281, 2020 | 42 | 2020 |
| The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology RF Belo, MLF Martins, L Shvachiy, T Costa-Coelho, C de Almeida-Borlido, ... Frontiers in Pharmacology 11, 985, 2020 | 12 | 2020 |
| A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease J Fonseca-Gomes, T Costa-Coelho, M Ferreira-Manso, S Inteiro-Oliveira, ... Molecular Therapy, 2024 | 1 | 2024 |
| Spatiotemporal Dysregulation of Neuron–Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the 5xFAD Mouse Model of Alzheimer’s Disease M Ianni, M Corraliza-Gomez, T Costa-Coelho, M Ferreira-Manso, ... International Journal of Molecular Sciences 25 (17), 9475, 2024 | 1 | 2024 |
| Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia− A GENFI study C Fenoglio, M Serpente, M Arcaro, T Carandini, L Sacchi, M Pintus, ... Brain, Behavior, and Immunity 122, 231-240, 2024 | | 2024 |
| Brain-derived neurotrophic factor modulation in response to oxidative stress and corticosterone: Role of scopolamine and mirtazapine AS Correia, M Torrado, T Costa-Coelho, E Carvalho, S Inteiro-Oliveira, ... Life Sciences, 123133, 2024 | | 2024 |
| Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study E Premi, M Diano, I Mattioli, D Altomare, V Cantoni, M Bocchetta, ... Brain Communications, fcae185, 2024 | | 2024 |
| Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study M Serpente, C Fenoglio, M Arcaro, T Carandini, L Sacchi, M Pintus, ... Journal of Alzheimer's Disease, 1-10, 2024 | | 2024 |
Maria José Diógenes在 campus.ul.pt 的电子邮件经过验证
